Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bevacizumab Versus Cidofovir for the Treatment of Recurrent Respiratory Papillomatosis: a Randomized, Double-blind, Placebo-controlled Clinical Trial

NCT02555800 is registered in ClinicalTrials.gov with Centro de Investigación en. Enfermedades Infecciosas, Mexico as lead sponsor.

NCT NCT02555800
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02555800 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bevacizumab Versus Cidofovir for the Treatment of Recurrent Respiratory Papillomatosis: a Randomized, Double-blind, Placebo-controlled Clinical Trial
Lead sponsor
Centro de Investigación en. Enfermedades Infecciosas, Mexico
Phase
Phase 2
Overall status
Unknown status
Start date
December 31, 2014
Completion date
June 30, 2017
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent respiratory papillomatosis